BiomSense develops biosensors that can detect particular kinds of bacteria in a patient's feces. The sensors are designed for patients to use in-home, using a toilet accessory that captures samples of the feces. The company was founded in 2018 and is based in Chicago, Illinois.
BiomeSense's Products & Differentiators
Novel technology for continuous, at-home tracking of the gut microbiome.
Research containing BiomeSense
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BiomeSense in 1 CB Insights research brief, most recently on Sep 20, 2022.
Expert Collections containing BiomeSense
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BiomeSense is included in 2 Expert Collections, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
BiomeSense has filed 3 patents.
Helminthiases, Toilets, Neglected diseases, Sanitation, Parasitic diseases
Helminthiases, Toilets, Neglected diseases, Sanitation, Parasitic diseases
Latest BiomeSense News
Oct 18, 2023
Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-022-01368-1 , published online 7 July 2022. In the version of the article initially published, a portion of the Competing interests statement was missing: “R.K. is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.” The text has been inserted in the HTML and PDF versions of the article. Author information Authors and Affiliations Collaborative Mass Spectrometry Innovation Center, University of California San Diego, La Jolla, CA, USA Julia M. Gauglitz, Kiana A. West, Wout Bittremieux, Kelly C. Weldon, Morgan Panitchpakdi, Francesca Di Ottavio, Christine M. Aceves, Nicole C. Sikora, Alan K. Jarmusch, Michael J. Meehan, Kathleen Dorrestein, Fernando Vargas, Katharina Spengler, Emmanuel O. Elijah, Mingxun Wang, Robert H. Mills & Pieter C. Dorrestein Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA Julia M. Gauglitz, Kiana A. West, Wout Bittremieux, Kelly C. Weldon, Morgan Panitchpakdi, Christine M. Aceves, Elizabeth Brown, Nicole C. Sikora, Alan K. Jarmusch, Anupriya Tripathi, Michael J. Meehan, Kathleen Dorrestein, Fernando Vargas, Emmanuel O. Elijah, Mingxun Wang, Robert H. Mills & Pieter C. Dorrestein Beckman Center for Conservation Research, San Diego Zoo Wildlife Alliance, Escondido, CA, USA Candace L. Williams Center for Microbiome Innovation, Joan and Irwin Jacobs School of Engineering, University of California San Diego, La Jolla, CA, USA Kelly C. Weldon, Cameron Martino, Pedro Belda-Ferre, Austin D. Swafford, Rob Knight & Pieter C. Dorrestein Division of Biological Sciences, University of California San Diego, La Jolla, CA, USA Elizabeth Brown, Anupriya Tripathi, Fernando Vargas & Rachel J. Dutton Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, USA Cameron Martino, Anupriya Tripathi, Justin P. Shaffer, Lindsay DeRight Goldasich, Tara Schwartz, MacKenzie Bryant, Gregory Humphrey, Pedro Belda-Ferre, Edgar Diaz, Daniel McDonald, Qiyun Zhu, Clarisse Marotz, Gail Ackermann, Robert H. Mills, Megan M. Doty, Kyung E. Rhee, Rob Knight & Pieter C. Dorrestein Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, CA, USA Cameron Martino Division of Rheumatology, Allergy & Immunology, Department of Medicine, University of California San Diego, La Jolla, CA, USA Roxana Coras, Robert Terkeltaub & Monica Guma Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA Abigail J. Johnson Kate E. Sprecher, Dana Withrow & Kenneth P. Wright Jr Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI, USA Kate E. Sprecher Servicio Autónomo Centro Amazónico de Investigación y Control de Enfermedades Tropicales Simón Bolívar, Puerto Ayacucho, Amazonas, Venezuela Daniela Vargas-Robles Lourdes Herrera Barry J. Bradford Department of Pharmacology, Ribeirão Preto Medicinal School, Center of Research in Inflammatory Diseases, University of São Paulo, Ribeirão Preto, Sao Paolo, Brazil Lucas Maciel Mauriz Marques, Flavio Protasio Veras & Thiago Mattar Cunha Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil Juliano Geraldo Amaral NPPNS, Department of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Sao Paolo, Brazil Rodrigo Moreira Silva & Norberto Peporine Lopes Department of Internal Medicine, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases, University of São Paulo, Ribeirão Preto, Sao Paolo, Brazil Rene Donizeti Ribeiro Oliveira & Paulo Louzada-Junior Department of Pharmacology, University of California San Diego, La Jolla, CA, USA Robert H. Mills & Pieter C. Dorrestein Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, USA Paulina K. Piotrowski, Stephanie L. Servetas, Sandra M. Da Silva, Christina M. Jones, Nancy J. Lin, Katrice A. Lippa & Scott A. Jackson Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA Rima Kaddurah Daouk Rima Kaddurah Daouk Rima Kaddurah Daouk Douglas Galasko Parambir S. Dulai & Brigid S. Boland Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA Tatyana I. Kalashnikova & Curt Wittenberg San Diego VA Healthcare System, San Diego, CA, USA Robert Terkeltaub Division of Neonatology, Department of Pediatrics, Kapi’olani Medical Center for Women and Children, John A. Burns School of Medicine, Honolulu, Hawaii, USA Megan M. Doty Division of Neonatology, Perinatal Institute, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA Jae H. Kim Division of Pediatric Hospital Medicine, Department of Pediatrics, University of California San Diego, La Jolla, CA, USA Julia Beauchamp-Walters Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences; Rutgers, The State University of New Jersey, New Brunswick, NJ, USA Maria Gloria Dominguez-Bello Mark Manary Michelli F. Oliveira & Rob Knight Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA Rob Knight Rob Knight
BiomeSense Frequently Asked Questions (FAQ)
When was BiomeSense founded?
BiomeSense was founded in 2018.
Where is BiomeSense's headquarters?
BiomeSense's headquarters is located at 1452 E 53rd Street, Chicago.
What is BiomeSense's latest funding round?
BiomeSense's latest funding round is Seed VC - IV.
How much did BiomeSense raise?
BiomeSense raised a total of $5M.
Who are the investors of BiomeSense?
Investors of BiomeSense include SOSV, Seerave Foundation, Bluestein Ventures, Harvest Ridge Capital, IndieBio and 5 more.
Who are BiomeSense's competitors?
Competitors of BiomeSense include Diversigen.
What products does BiomeSense offer?
BiomeSense's products include GutLab and 1 more.
Compare BiomeSense to Competitors
Diversigen provides metagenomic services and data analysis for solutions that improve health, the environment, agriculture, and oil and gas production worldwide. On November 6, 2019, Diversigen was acquired by OraSure Technologies at a valuation of $12M.